Skip to main content
. 2021 Jan 17;8(1):e000544. doi: 10.1136/bmjgast-2020-000544

Table 2.

Investigations at follow-up clinic appointments

Coeliac IBD P value Adjusted P value General P value Adjusted P value
Bloods 83 (81.4%) 43 (43.4%) <0.001 <0.001 26 (72.2%) 0.247
Genetic testing 13 (12.7%) 0 (0%) <0.001* 0.002 3 (8.3%) 0.562*
Gastroscopy 21 (20.6%) 1 (1.0%) <0.001 <0.001 6 (16.7%) 0.610
Colonoscopy 7 (6.9%) 16 (16.2%) 0.038 0.38 1 (2.8%) 0.680*
Flexible sigmoidoscopy 1 (1.0%) 3 (3.0%) 0.364* 0 (0%) 1.000*
Capsule endoscopy 2 (2.0%) 5 (5.1%) 0.274* 0 (0%) 1.000*
Imaging 4 (4.0%) 10 (10.1%) 0.085 1 (2.8%) 1.000*
SeHCAT test 2 (2.0%) 2 (2.0%) 1.000* 0 (0%) 1.000*
DXA scan 15 (14.7%) 0 (0%) <0.001 <0.001 5 (13.9%) 0.905
Breath tests 2 (2.0%) 3 (3.0%) 0.678* 0 (0%) 1.000*
Mean number of investigations (±SD) 2.19 (±1.41) 1.93 (±1.35) <0.001 1.44 (±1.23) 0.054

Bold denotes a significant value with p<0.05.

*One or more of the cells in 2×2 table have an expected count <5, Fisher’s exact test is used to calculate p values.

DXA, dual energy x-ray absorptiometry; IBD, inflammatory bowel disease; SeHCAT, selenium homocholic acid taurine.